Behcet's disease: Is there geographical variation? A review far from the silk road

International Journal of Rheumatology

Volumn 2015, Issue , 2015, Pages

  Leonardo, Nieves Marie ^a,b   McNeil, Julian ^a,b  

^a MODBURY HOSPITAL   (Australia)

^b UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ANTICOAGULANT AGENT; ANTIFIBRINOLYTIC AGENT; ANTITHROMBOCYTIC AGENT; AZATHIOPRINE; COLCHICINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; NONSTEROID ANTIINFLAMMATORY AGENT; SALAZOSULFAPYRIDINE; STEROID;

ANEURYSM; ARTHRITIS; ARTHROPATHY; BEHCET DISEASE; CLINICAL FEATURE; COMORBIDITY; DEEP VEIN THROMBOSIS; DIAGNOSTIC TEST; EPIDEMIOLOGICAL DATA; EYE DISEASE; GASTROINTESTINAL SYMPTOM; GEOGRAPHIC PATHOLOGY; GEOGRAPHICAL VARIATION; HEART DISEASE; HUMAN; LUNG DISEASE; NEUROLOGIC DISEASE; PATHOGENESIS; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SKIN MANIFESTATION; TREATMENT INDICATION; UROGENITAL TRACT DISEASE; VASCULITIS; VEIN THROMBOSIS;

EID: 84954474147     PISSN: 16879260     EISSN: 16879279     Source Type: Journal    
DOI: 10.1155/2015/945262     Document Type: Review

References (45)

1. J. C. Jennette, R. J. Falk, P. A. Bacon et al., "2012 Revised International Chapel Hill consensus conference nomenclature of vasculitides," Arthritis and Rheumatism, vol. 65, no. 1, pp. 1-11, 2013.
2. S. B. Cho, S. Cho, and D. Bang, "New insights in the clinical understanding of Behçets disease," Yonsei Medical Journal, vol. 53, no. 1, pp. 35-42, 2012.
3. D. Saadoun and B. Wechsler, "Behçets disease," Orphanet Journal of Rare Diseases, vol. 7, no. 1, article 20, 2012.
4. C. C. Zouboulis and W. Keitel, "A historical review of early descriptions of Adamantiades-Behçets disease," Journal of Investigative Dermatology, vol. 119, no. 1, pp. 201-205, 2002.
5. H. Keino and A. Okada, "Behcets disease: global epidemiology of an Old Silk Road disease," British Journal of Ophthalmology, vol. 91, pp. 1573-1574, 2007.
6. A. Mohammad, T. Mandl, G. Sturfelt, and M. Segelmark, "Incidence, prevalence and clinical characteristics of Behçets disease in southern Sweden," Rheumatology, vol. 52, no. 2, pp. 304-310, 2013.
7. D. Wakefield and P. McCluskey, "Behcets syndrome: ocular features in anAustralian population," Australian and New Zealand Journal of Ophthalmology, vol. 18, no. 2, pp. 129-135, 1990.
8. A. Mahr, L. Belarbi, B. Wechsler et al., "Population-based prevalence study of Behçets disease: differences by ethnic origin and low variation by age at immigration," Arthritis and Rheumatism, vol. 58, no. 12, pp. 3951-3959, 2008.
9. F. Davatchi, F. Shahram, C. Chams-Davatchi et al., "Behcets disease: fromeast towest," Clinical Rheumatology, vol. 29, no. 8, pp. 823-833, 2010.
10. D. Bang, S. Oh, K.-H. Lee, E.-S. Lee, and S. Lee, "Influence of sex on patients with Behçets disease in Kore," Journal of Korean Medical Science, vol. 18, no. 2, pp. 231-235, 2003.
11. K. H. Lee, H.-S. Chung, H. S. Kim et al., "Human α-enolase fromendothelial cells as a target antigen of anti-endothelial cell antibody in Behçets disease," Arthritis and Rheumatism, vol. 48, no. 7, pp. 2025-2035, 2003.
12. D. H. Verity, G. R. Wallace, R. W. Vaughan, and M. R. Stanford, "Behçets disease: from Hippocrates to the third millennium," British Journal of Ophthalmology, vol. 87, no. 9, pp. 1175-1183, 2003.
13. S. Yilmaz and K. A. Cimen, "Familial Behçets disease," Rheumatology International, vol. 30, no. 8, pp. 1107-1109, 2010.
14. T. Chajek-Shaul, S. Pisanty, H. Knobler et al., "HLA-B51 may serve as an immunogenetic marker for a subgroup of patients with Behçets syndrome,"The American Journal ofMedicine, vol. 83, no. 4, pp. 666-672, 1987.
15. J. L. Villanueva, J. Gonzalez-Dominguez, R. Gonzalez-Fernandez, J. L. Prada, J. Pena, and R. Solana, "HLA antigen familial study in complete Behcets syndrome affecting three sisters," Annals of the RheumaticDiseases, vol. 52, no. 2, pp. 155-157, 1993.
16. International Study Group for Behçets Disease, "Criteria for diagnosis of Behçets disease," The Lancet, vol. 335, no. 8697, pp. 1078-1080, 1990.
17. International Teamfor the Revision of the InternationalCriteria for BehçetsDisease (ITR-ICBD), "TheInternationalCriteria for Behçets Disease (ICBD): a collaborative study of 27 countries on the sensitivity and specificity of the new criteria," Journal of the European Academy of Dermatology and Venereology, vol. 28, no. 3, pp. 338-347, 2014.
18. A. Varol, O. Seifert, and C. D. Anderson, "The skin pathergy test: innately useful?" Archives of Dermatological Research, vol. 302, no. 3, pp. 155-168, 2010.
19. F. Davatchi, C. Chams-Davatchi, Z. Ghodsi et al., "Diagnostic value of pathergy test in Behcets disease according to the change of incidence over the time," Clinical Rheumatology, vol. 30, no. 9, pp. 1151-1155, 2011.
20. N. Kitaichi, A. Miyazaki, D. Iwata, S. Ohno, M. R. Stanford, and H. Chams, "Ocular features of Behçets disease: an international collaborative study," British Journal of Ophthalmology, vol. 91, no. 12, pp. 1579-1582, 2007.
21. B. Coskun, Y. Saral, A. Gödekmerdan, I. Erden, and N. Coskun, "Activation markers in Behçets disease," Skinmed, vol. 4, no. 5, pp. 282-286, 2005.
22. S. E. Marshall, "Behçets disease," Best Practice and Research: Clinical Rheumatology, vol. 18, no. 3, pp. 291-311, 2004.
23. M. Altac, Y. Tuzun, S. Yurdakul, P. Binyildiz, and H. Yazici, "The validity of the pathergy test (non-specific skin hyperreactivity) in Behcets disease: a double-blind study by independent observers," Acta Dermato-Venereologica, vol. 62, no. 2, pp. 158-159, 1982.
24. M. Mesquida, B. Molins, V. Llorenç et al., "Current and future treatments for Behçets uveitis: road to remission," International Ophthalmology, vol. 34, no. 2, pp. 365-381, 2014.
25. L. Mirone, L. Altomonte, E. M. Ferlisi, A. Zoli, and M. Magaro, "Behçets disease and cardiac arrhythmia," Clinical Rheumatology, vol. 16, no. 1, pp. 99-100, 1997.
26. E. B. Kaya, H. Yorgun, A. Akdogan et al., "Heart-rate recovery index is impaired in Behçets disease," Texas Heart Institute Journal, vol. 36, no. 4, pp. 282-286, 2009.
27. N. K. Eryol, R. Topsakal, A. Abaci, and A. Oguzhan, "A case of atrioventricular complete block due to Behçets disease," Japanese Heart Journal, vol. 43, no. 6, pp. 697-701, 2002.
28. C. Gürgün, E. Ercan, C. Ceyhan et al., "Cardiovascular involvement in Behçets disease," Japanese Heart Journal, vol. 43, no. 4, pp. 389-398, 2002.
29. N. Düzgün and A. Ateş, "Erosive arthritis in a patient with Behçets disease," Rheumatology International, vol. 23, no. 5, pp. 265-267, 2003.
30. S. Benamour, B. Zeroual, and F.-Z. Alaoui, "Joint manifestations in Behcets disease: a review of 340 cases," Revue du Rhumatisme, vol. 65, no. 5, pp. 299-307, 1998.
31. A. ElMaghraoui, F. Tabache, A. Bezza et al., "A controlled study of sacroiliitis in Behçets disease," Clinical Rheumatology, vol. 20, no. 3, pp. 189-191, 2001.
32. C. Arkin, B. Rothschild, N. Fluorendo, and N. Popoff, "Myopathy in Behcet syndrome," Arthritis and Rheumatology, vol. 23, pp. 600-604, 1980.
33. G. Akman-Demir, P. Serdaroglu, and B. Tasçi, "Clinical patterns of neurological involvement in Behcets disease: evaluation of patients," Brain, vol. 122, part 11, pp. 2171-2181, 1999.
34. F. G. Joseph and N. J. Scolding, "Neuro-Behçets disease in Caucasians: a study of 22 patients," European Journal of Neurology, vol. 14, no. 2, pp. 174-180, 2007.
35. F. Davatchi, F. Shahram, C. Chams, H. Chams, and A. Nadji, "Behçets disease," Acta Medica Iranica, vol. 43, no. 4, pp. 233-242, 2005.
36. D. Saadoun, B. Asli, B. Wechsler et al., "Long-term outcome of arterial lesions in Behçet disease: a series of 101 patients," Medicine, vol. 91, no. 1, pp. 18-24, 2012.
37. V. Hamuryudan, T. Er, E. Seyahi et al., "Pulmonary artery aneurysms in Behçet syndrome," The American Journal of Medicine, vol. 117, no. 11, pp. 867-870, 2004.
38. K. A. Lewis, E. M. Graham, and M. R. Stanford, "Systematic review of ethnic variation in the phenotype of Behcets disease," Scandinavian Journal of Rheumatology, vol. 36, no. 1, pp. 1-6, 2007.
39. J. H. Chang, J. Landers, T. R. M. Henderson, and J. E. Craig, "Prevalence of uveitis in indigenous populations presenting to remote clinics of central Australia: the Central Australian Ocular Health Study," Clinical and Experimental Ophthalmology, vol. 40, no. 5, pp. 448-453, 2012.
40. P. R. J. Ames, A. Steuer, A. Pap, and A. M. Denman, "Thrombosis in Behçets disease: a retrospective survey from a single UK centre," Rheumatology, vol. 40, no. 6, pp. 652-655, 2001.
41. G. Hatemi, A. Silman, D. Bang et al., "EULAR recommendations for the management of Behçet disease," Annals of the Rheumatic Diseases, vol. 67, no. 12, pp. 1656-1662, 2008.
42. R. J. Barry, B. Markandey, R. Malhotra et al., "Evidence-based practice in Behçets disease: identifying areas of unmet need for 2014," Orphanet Journal of Rare Diseases, vol. 9, no. 1, article 16, 2014.
43. Y. Yazici, S. Yurdakul, and H. Yazici, "Behçets syndrome," Current Rheumatology Reports, vol. 12, no. 6, pp. 429-435, 2010.
44. R. S. Tunes, T. C. Anjos, G. B. Martins, E. R. M. Barreto, and M. B. Santiago, "Prevalence of Behcets syndrome in patients with recurrent aphthous ulcerations in Brazil," Rheumatology International, vol. 29, no. 8, pp. 875-878, 2009.
45. F. Davatchi, "Diagnosis/classification criteria for behcets disease," Pathology Research International, vol. 2012, Article ID 607921, 5 pages, 2012.